Investigator
The University of Birmingham
Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies
Ovarian cancer has the worst case-to-fatality ratio of all gynecologic malignancies. The main reasons for the high mortality rate are relapse and the development of chemoresistance. In this paper, the cytotoxic activity of two new multiaction platinum(IV) derivatives of cisplatin and oxaliplatin in a panel of ovarian cancer cells is reported.
Researcher
Professor (Associate) in Medicinal Chemistry
University of Birmingham · School of Pharmacy
Honorary Contract
Birmingham and Solihull Mental Health NHS Foundation Trust · Research
Senior Lecturer in Pharmaceutical Chemistry
Manchester Metropolitan University · Chemistry
Postdoctoral Fellow
Institute of Cancer Research · Cancer Therapeutics
Postdoctoral Research Associate
University of Oxford · Chemistry
Advanced HE - Certificate of Professional Development Course for External Examiners
Cardiff University
PGCAP
Manchester Metropolitan University
Ph.D.
St Andrews University · Chemistry
BSc (Hons)
University of Aberdeen · Chemistry
GB
